Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer

dc.contributor.authorLara, Ester
dc.contributor.authorCalvanese, Vincenzo
dc.contributor.authorHuidobro, Covadonga
dc.contributor.authorFernández, Agustín F.
dc.contributor.authorMoncada Pazos, Ángela
dc.contributor.authorObaya, Álvaro J.
dc.contributor.authorAguilera, Oscar
dc.contributor.authorGonzález Sáncho, José Manuel
dc.contributor.authorSánchez, Laura
dc.contributor.authorAstudillo, Aurora
dc.contributor.authorMuñoz, Alberto
dc.contributor.authorLópez-Otin, Carlos
dc.contributor.authorEsteller, Manel, 1968-
dc.contributor.authorFraga, Mario F.
dc.date.accessioned2018-12-10T09:08:28Z
dc.date.available2018-12-10T09:08:28Z
dc.date.issued2010-06-30
dc.date.updated2018-07-24T13:04:56Z
dc.description.abstractBackground: Wnt factors control cell differentiation through semi-independent molecular cascades known as the beta-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of the primary mechanisms underlying colon cancer. Despite increasing evidence of the role of the non-canonical pathways in tumourigenesis, however, the underlying molecular mechanisms are poorly understood. Results: Here we report that the receptor tyrosine kinase-like orphan receptor 2 (ROR2), a transmembrane receptor for Wnt factors that activates non-canonical pathways, is frequently repressed by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumours. By restoring ROR2 activity in colon cancer cells harbouring ROR2 promoter hypermethylation, we show that the role of ROR2 in colon cancer cells is mediated, at least in part, by canonical Wnt and that its epigenetic-dependent loss can be pro-tumourigenic. Conclusions: Our data show the importance of epigenetic alterations of ROR2 in colon cancer, highlighting the close interconnection between canonical and non-canonical Wnt signalling pathways in this type of tumour.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec700237
dc.identifier.pmid20591152
dc.identifier.urihttps://hdl.handle.net/2445/126808
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/1476-4598-9-170
dc.relation.ispartofMolecular Cancer, 2010, vol. 9, num. 170
dc.relation.urihttps://doi.org/10.1186/1476-4598-9-170
dc.rightscc by (c) Lara et al., 2010
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationCàncer colorectal
dc.subject.otherColorectal cancer
dc.titleEpigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
LaraE.pdf
Mida:
1.19 MB
Format:
Adobe Portable Document Format